Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.
ImportFab is a well-established contract manufacturer, specializing in the manufacturing and packaging of semi-solid and liquid products for the pharmaceutical, cosmetic and nutraceutical market. With 30 years of experience, the company has a very strong customer base. ImportFab is accredited by Health Canada and the US FDA.
Headquartered in Italy, Labomar is a reliable partner with over twenty years experience offering its customers effective, quality, front-line solutions in the field of food supplements, medical devices, cosmetics, as well as foods for special medical purposes. Labomar is engaged in production on behalf of third parties, providing a complete service ranging from selection of the raw materials to delivery of the finished product. The heart and soul of its activity is the research and development department, guaranteeing constant innovation and quality.
Oaklins' team in Canada advised the seller, contacted over 100 potential buyers through its international teams and negotiated the terms of the transaction. Oaklins' team in Italy introduced Labomar and assisted throughout the process.



Sylvain Renzi
Founder, Enterprises ImportFab, Inc.
Talk to the deal team




Related deals
Groupe Nature acquires Winco
Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.
Learn moreCamelia pharmacy chain has been acquired by Medigate Management UAB
CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.
Learn moreShield Therapeutics has raised funds
Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.
Learn more